Exhibit 99.1

FOR IMMEDIATE RELEASE

                   CONSUMER DEMAND FOR MARVEL BRANDED PRODUCTS
                    PROPELS COMPANY TO STRONG Q3 PERFORMANCE;
                              RAISES 2003 GUIDANCE

New York, New York - November 4, 2003 -- Marvel Enterprises, Inc. (NYSE: MVL), a
global provider of entertainment  content,  today reported financial results for
its third quarter ended September 30, 2003 and raised its financial guidance for
the year ending  December 31, 2003.  For the three month period ended  September
30,  2003,  Marvel  reported net income of $63.2  million,  or $0.85 per diluted
share,  which includes a one-time  non-cash gain of $31.5 million,  or $0.42 per
diluted  share,  as a result  of  recording  an asset on its  balance  sheet for
Federal net operating loss carry-forwards.



                      SUMMARY FINANCIAL RESULTS (Unaudited)
                                                                          Three Months Ended             Nine Months Ended
(In thousands, except per share data)                                   9/30/03       9/30/02          9/30/03       9/30/02
                                                                       ------------- ------------- --------------- -------------
                                                                                                        
Net sales                                                               $84,536       $84,378         $261,878      $212,539
Operating income                                                         43,078        27,739          141,172        57,457
Net income attributable to common stock per diluted share                 $0.85         $0.17            $1.84         $0.08


Marvel  President and CEO,  Allen Lipson,  commented,  "The first nine months of
2003 reflect the  strength and cash  generation  power of our  licensing  driven
business  model  as well as the  growing  influence  of the  `Marvel'  brand  on
consumers and retailers.  Marvel-branded  consumer  products continue to achieve
high levels of `sell-through'  at retail,  causing many of our 550+ licensees to
achieve  sales  results  substantially  in excess of their  contractual  minimum
guarantees.  Our third quarter  results  benefited  from a  particularly  strong
performance of products based on The Incredible Hulk and Spider-Man  characters,
as well as growing  momentum  from our full library of  characters.  Through the
first  nine  months  of  2003,  licensing  net  sales  derived  from  properties
associated  with  movies  released  in 2003  (Daredevil,  X-Men  and  The  Hulk)
accounted for roughly 48% of total licensing net sales.


                            Marvel Enterprises, Inc.
                Divisional Net Sales/Operating income (Unaudited)

                                          Three Months Ended              Nine Months Ended
(dollars in thousands)                  9/30/03        9/30/02         9/30/03        9/30/02
                                        -----------------------      ------------------------------
                                                                         
Licensing:       Net Sales              $41,638       $ 25,007       $148,289        $ 51,335
                 Operating Income        30,267         22,514        120,332          43,270
Publishing:      Net Sales               19,553         15,345         54,300          47,846
                 Operating Income         7,042          4,433         18,301          14,397
Toys:            Net Sales               23,345         44,026         59,289         113,358
                 Operating Income         8,212          4,151         16,765           9,050
Corporate Overhead:                      (2,443)        (3,359)       (14,226)         (9,260)
          TOTAL NET SALES               $84,536        $84,378       $261,878        $212,539
          TOTAL OPERATING INCOME         43,078         27,739        141,172          57,457



Divisional  Review:
o    Marvel's  Licensing  Division benefited from continued strength in consumer
     product  licensing,  with growth in both the number of new licenses as well
     as royalty collections above minimum guarantees. License revenues in excess
     of minimum  guarantees,  or  "overages,"  were  roughly  $13 million in the
     quarter,  demonstrating  strong  sales  momentum  from a  growing  base  of
     products.  Sales of consumer  products  based on the feature  film The Hulk
     continued  to sell  during  the  quarter  at levels  in excess of  internal
     projections.  Hulk  and  all  other  Marvel  character  action  figure  and
     accessory  toy lines (except for  Spider-Man:  The Movie toys) are produced
     and  sold  by  Marvel's  licensee,  Toy Biz  Worldwide  Ltd.,  with  Marvel
     recording related royalty income within its licensing segment. The creative
     and marketing talents of Marvel's in-house toy division are responsible for
     the design, marketing and sales representation of all Marvel-character toys
     manufactured and sold by Toy Biz Worldwide Ltd.




o    Marvel's  Publishing  Division net sales  increased  due to  re-invigorated
     growth in comic sales and continued  momentum in trade  paperback sales and
     advertising  income.  Comic sales benefited from new landmark projects such
     as  JLA/Avengers,  1602 and  Supreme  Power,  which all had  stronger  than
     expected  retail  "sell-through."  187 titles  were  shipped in the quarter
     versus 181 in the year-ago period.

o    As  anticipated  in previous  announcements,  Marvel's Toy  Division  sales
     decreased in Q3 2003 as sales of action  figures and  accessories  based on
     Spider-Man:  The Movie  declined to $5.9 million  from $34.5  million in Q3
     2002.  Operating  margins  were roughly 34% in Q3 2003 versus 9% in Q3 2002
     and 28% in the first nine months of 2003 versus 8% in the first nine months
     of 2002. The improvement in operating  margins versus the year-ago  periods
     was fueled by a more favorable sales mix and lower royalty  expense.  Sales
     of Spectra Star kites,  which carry lower margins,  were also significantly
     lower quarter-to-quarter as this business is being phased out.

o    Corporate  Overhead  decreased  significantly  from the June 2003  quarter,
     reflecting more normalized  historical  levels. The Company settled certain
     ongoing legal disputes  during the period and other legal matters moved out
     of active litigation phases, thereby reducing expenses.

Increasing Net Cash Position:
Marvel had $211.2 million in cash,  certificates of deposit and commercial paper
and $151.0 million owed to holders of 12% Senior Notes as of September 30, 2003,
or net cash of $60.2 million. This cash balance includes $16 million in proceeds
received  from the  exercise of options and warrants  during the  quarter.  This
compares  to cash of $144.3  million and $151.0  million  owed to holders of 12%
Senior Notes as of June 30, 2003, or net debt of $6.7 million.  The Senior Notes
are callable at Marvel's  option  beginning June 15, 2004 at a price of $106 per
$100 principal amount, for a total consideration of approximately $160 million.


                                       2




Marvel Character Feature Film Line-Up For 2004
(Release dates and development timing are controlled by Studio partners)
- ---------------------------------------------------------------------------------------------------
                                                                  
Film/Character                    Studio/Distributor               Targeted Release Date
- --------------------------------- -------------------------------- --------------------------------
The Punisher                      Artisan Entertainment            April 16, 2004
- --------------------------------- -------------------------------- --------------------------------
Spider-Man 2                      Sony/Columbia                    July 2, 2004
- --------------------------------- -------------------------------- --------------------------------
Blade 3                           New Line Cinema                  August 12, 2004
- --------------------------------- -------------------------------- --------------------------------
Man-Thing                         Fierce/Artisan                   August 26, 2004
- --------------------------------- -------------------------------- --------------------------------
Fantastic Four                    Fox                              December 24, 2004
- --------------------------------- -------------------------------- --------------------------------




Marvel Character Entertainment Projects in Development
(Development timing is controlled by Studio partners)
- --------------------------------- -------------------------------- --------------------------------
                                                                  
Film/Character                    Studio/Distributor               Format
- --------------------------------- -------------------------------- --------------------------------
X-Men 3                           Fox                              Film
- --------------------------------- -------------------------------- --------------------------------
The Hulk 2                        Universal Pictures               Film
- --------------------------------- -------------------------------- --------------------------------
Namor                             Universal Pictures               Film
- --------------------------------- -------------------------------- --------------------------------
Elektra                           New Regency / Fox                Film
- --------------------------------- -------------------------------- --------------------------------
Iron Man                          New Line Cinema                  Film
- --------------------------------- -------------------------------- --------------------------------
Ghost Rider                       Sony                             Film
- --------------------------------- -------------------------------- --------------------------------
DeathLok                          Crystal Sky/Paramount Pictures   Film
- --------------------------------- -------------------------------- --------------------------------
Blade Animation                   MTV                              TV
- --------------------------------- -------------------------------- --------------------------------


Financial Guidance:
Reflecting  Marvel's  stronger than anticipated  year-to-date  performance,  the
Company  has  raised  its  guidance  for the full  year  2003,  as noted  below.
Following  final board review and approval of  divisional  budgets,  Marvel will
provide further financial guidance ranges for 2004 shortly before November 18th,
the date of its analyst day webcast.  Preliminary  indications suggest that 2004
operating income will exceed Marvel's 2003 operating income. 2004 net income and
earnings  per share will likely fall below 2003 levels,  primarily  reflecting a
change in Marvel's tax provision to approximately  37% in 2004,  compared to 17%
in 2003 - excluding the one-time non-cash income tax benefit described above.



                            Marvel Enterprises, Inc.
                               Financial Guidance

                                                    Actual Q4     Updated 2003        Previous         Actual
(in millions - except per share       Q4 2003         2002         Guidance            2003            FY '02
amounts)                             Guidance        Results                          Guidance        Results
- --------------------------------- ---------------- ----------- ----------------- ------------------ -------------
                                                                               
Net sales                            $62 - $67       $86.5        $324 - $329       $311 - $315        $299.0
Operating Income                     $18 - $23       $23.0        $159 - $164       $143 - $146         $80.3
Net income (1)                        $8 - $12        $7.2        $146 - $150       $105 - $108         $22.6
EPS attributable to common stock
(1) (2) (3) (4)                    $0.10 - $0.16     ($1.03)     $1.94 - $2.00     $1.38 - 1.42         $(1.18)
Weighted average diluted common
shares                                     74.2       47.3               75.0             76.8           38.5
- ---------------------------------- ---------------- ----------- ----------------- ------------------ -------------


(1) FY 2003 net income and EPS  attributable  to common stock includes the $31.5
million  one-time,  non-cash  benefit  that  arises  from the  valuation  of NOL
carry-forwards.  FY 2002 net income and EPS attributable to common stock include
the impact of the non-cash SFAS 142  impairment  charge of $4.2 million.

(2) FY 2002 EPS  attributable to common stock includes a $55.3 million  one-time
non-cash  charge related to the completion of Marvel's  Preferred Share exchange
offer.

(3) FY 2002 net income  and EPS  attributable  to common  stock is net of a $9.4
million  non-cash  charge related to the  amortization  of HSBC credit  facility
costs,  warrants issued to Isaac  Perlmutter and senior note offering costs. The
amounts also include $11.8 million in non-cash loan cost  amortization  that was
accelerated into FY 2002 as a result of Marvel's prepayments of its bank debt in
2002.

                                       3


(4) FY 2003  EPS  attributable  to  common  stock is net of  approximately  $1.2
million in preferred  stock  dividends.  Q4 2002 & FY 2002 EPS  attributable  to
common stock reflect approximately $4.0 million and $68.1 million (including the
above one-time, non-cash charge of $55.3 million for FY 2002) in preferred stock
dividends, respectively.

Q4 2003  Highlights  - Marvel  believes  that  licensing  sales will account for
roughly 37% of net sales in the quarter, fueled by continued momentum in toy and
consumer  product  license   revenues.   Sales  in  Marvel's  toy  division  are
anticipated  to  increase  from Q3 2003  levels due to the  release of an action
figure  and  accessory  line based on the third  installment  of the Lord of the
Rings feature film trilogy and the shipment to retailers of some products  based
on the  upcoming  Spider-Man  II movie.  The  effective  tax rate for Q4 2003 is
anticipated  to be 37%,  resulting  from  recording  a  value  for  Federal  net
operating loss  carry-forwards in Q3 2003.  Corporate overhead is anticipated to
be slightly higher than Q3 2003 levels.

Marvel  cautions  investors  that inherent  variability in the timing of license
opportunities and entertainment events, the timing of their revenue recognition,
and  their  relative  success   contributes  to  sequential  and  year-over-year
variability in its interim financial results and could have a material impact on
quarterly results.

About Marvel Enterprises
Marvel  Enterprises,  Inc.  is a leading  global  character-based  entertainment
licensing company that has developed and owns a library of over 4,700 characters
which have entertained  generations around the world for over 60 years. Marvel's
operations are focused in entertainment and consumer product licensing and comic
book publishing.  Marvel's  creative teams at its Marvel Studios,  Marvel Comics
and Toy Biz divisions  support the development of feature films (and DVD/video),
video  games,  TV series  and toy lines  based on its  characters.  Marvel  also
licenses  its  characters  for use in a broad  and  growing  range  of  consumer
products and services  including  apparel,  collectibles,  food and  promotions.
Marvel Comics is a leading global comics  publisher and an invaluable  source of
intellectual property; Marvel Studios works with studios to develop feature film
and  entertainment  projects;  and Toy Biz is a recognized leader in toy design,
sales and  marketing  that  develops and oversees both licensee and in-house toy
lines. For additional information visit http://www.marvel.com.

Except for any historical  information that they contain, the statements in this
news release regarding  Marvel's plans are  forward-looking  statements that are
subject to certain risks and uncertainties, including a decrease in the level of
media exposure or popularity of Marvel's characters,  financial  difficulties of
Marvel's    licensees,    changing    consumer    preferences,     movie-    and
television-production   delays  and  cancellations,   toy-production  delays  or
shortfalls,  continued  concentration of toy retailers,  toy inventory risk, the
imposition of quotas or tariffs on products manufactured in China and a decrease
in cash flow even as Marvel remains indebted to its noteholders. These and other
risks and  uncertainties  are described in Marvel's  filings with the Securities
and  Exchange  Commission,  including  Marvel's  Annual  Reports  on Form  10-K,
Quarterly  Reports on Form 10-Q and Current  Reports on Form 8-K. Marvel assumes
no obligation to publicly update or revise any forward-looking statements.


For further information contact:
Matt Finick                                          Richard Land, David Collins
Marvel Enterprises                                   Jaffoni & Collins
212/576-4035                                         212/835-8500
mfinick@marvel.com                                   mvl@jcir.com
                                                     ------------

                                - tables follow -

                                       4




                            Marvel Enterprises, Inc.
              Summary Consolidated Statements Of Income (Unaudited)
                      (in thousands, except per share data)

                                                                     Three Months Ended       Nine Months Ended
                                                                        September 30,           September 30,
                                                                      2003         2002       2003          2002
- -------------------------------------------------------           ----------------------   ----------------------
                                                                                            
Net sales                                                         $  84,536    $  84,378   $ 261,878    $ 212,539
Cost of sales                                                        20,208       41,100      57,634      104,163
Gross profit                                                         64,328       43,278     204,244      108,376
Selling, general and administrative expenses                         22,569       16,015      70,163       55,188
Depreciation and amortization                                         1,051        1,675       2,808        3,897
Total Operating Expenses                                             23,620       17,690      72,971       59,085
Other income                                                            870          366       1,413        1,040
Equity in net income of joint venture                                 1,500        1,785       8,486        7,126
Operating income                                                     43,078       27,739     141,172       57,457
Interest expense, net (1)                                             4,239       12,086      13,072       27,725
Income before income taxes                                           38,839       15,653     128,100       29,732
Income tax provision (benefit) - current                              3,212          941       6,331        1,651
                               - deferred (2)                       (27,551)       4,076     (16,384)       8,304
Income before cumulative effect of change in accounting
principle                                                            63,178       10,636     138,153       19,777
Cumulative effect of change in
  accounting principle, net of taxes                                   --            175        --         (4,386)
Net income                                                        $  63,178    $  10,811   $ 138,153    $  15,391
Preferred dividend requirement                                         --          4,080       1,163       12,216
Net income attributable to common shares (3)                      $  63,178    $   6,731   $ 136,990    $   3,175
Diluted net income per common share (2)                           $    0.85    $    0.17   $    1.84    $    0.08
Weighted average number of
  diluted common shares                                              74,214       40,586      75,226       40,448

(1)  FY 2002 nine months interest expense include $5.4 million in non-cash items
     related to the amortization of HSBC loan costs, warrants issued to Isaac
     Perlmutter and senior note offering costs.
(2)  2003 three and nine month results include a one-time non-cash gain of $31.5
     million, or $0.42 per diluted share, as a result of the Company recording a
     value for unused Federal NOL carry-forwards in the period.
(3)  Results for the nine month period ended September 30, 2002 include the
     impact of the non-cash SFAS 142 impairment charge of $4.4 million.




                                       5




                            Marvel Enterprises, Inc.
                           Consolidated Balance Sheets
                                 (in thousands)

                                                                        September 30,  December 31,
                                                                            2003          2002
                                                                            ----          ----
ASSETS                                                                   (Unaudited)
Current assets:
                                                                                
 Cash                                                                    $  17,733    $  53,690
 Certificates of deposits and commercial paper                             193,507         --
 Accounts receivable, net                                                   42,980       43,420
 Inventories, net                                                           10,269       16,036
 Distribution receivable from joint venture, net                             1,413        3,884
 Deferred Federal income tax                                                33,967         --
 Deferred financing costs                                                      667          667
 Prepaid expenses and other current assets                                   6,639        6,700
                                                                         ---------    ---------
     Total current assets                                                  307,175      124,397

 Goodwill, net                                                             350,500      365,604
 Other intangibles, net                                                        414          649
 Molds, tools and equipment, net                                             6,016        6,997
 Product and package design costs, net                                       1,445          859
 Accounts receivable, non-current portion                                   19,470       17,284
 Deferred charges and other assets                                              53           65
 Deferred financing costs                                                    2,946        3,446
                                                                         ---------    ---------
     Total assets                                                        $ 688,019    $ 519,301
                                                                         =========    =========

LIABILITIES,  REDEEMABLE CONVERTIBLE PREFERRED STOCK
AND STOCKHOLDERS' EQUITY
Current liabilities:
 Accounts payable                                                        $   6,638    $  11,607
 Accrued expenses and other current liabilities                             75,853       52,708
 Deferred revenue and distributions in excess of equity in joint
venture                                                                     10,493       27,478
                                                                         ---------    ---------
     Total current liabilities                                              92,984       91,793
                                                                         ---------    ---------

Senior notes                                                               150,962      150,962
 Other                                                                       3,237          897
                                                                         ---------    ---------
     Total liabilities                                                     247,183      243,652
                                                                         ---------    ---------

Cumulative convertible exchangeable redeemable preferred stock                --         32,780
                                                                         ---------    ---------

Stockholders' equity
 Common stock                                                                  793          685
 Additional paid-in capital                                                546,869      486,106
 Accumulated deficit                                                       (71,429)    (208,419)
 Accumulated other comprehensive loss                                       (2,442)      (2,548)
                                                                         ---------    ---------

     Total stockholders' equity before treasury stock                      473,791      275,824
 Treasury stock                                                            (32,955)     (32,955)
                                                                         ---------    ---------

     Total stockholders' equity                                            440,836      242,869
                                                                         ---------    ---------

     Total liabilities, cumulative convertible exchangeable redeemable
      preferred stock and stockholders' equity                           $ 688,019    $ 519,301
                                                                         =========    =========



                                       6

                                      # # #